Log in
Enquire now
Oraya Therapeutics

Oraya Therapeutics

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/oraya-therapeutics
B2X
B2B
B2B
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...apeutics
Date Incorporated
2007
Email Address
info@orayainc.com
info.meditec@zeiss.com
0
Facebook URL
@zeissmedicaltechnologyglobal
Founded Date
2007
Founder
‌
Michael Gertner
0
Full Address
8000 Jarvis Ave., Suite 200, Newark, CA 94560, US
0
Glassdoor ID
273499
Industry
Technology
Technology
Biotechnology
Biotechnology
Health technology
Health technology
Therapeutics
Therapeutics
Medical device
Medical device
Radiation therapy
Radiation therapy
Healthcare
Healthcare
Biology
Biology
Investors
Domain Associates
Domain Associates
Scale Venture Partners
Scale Venture Partners
Latest Funding Round Date
July 20, 2009
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/oraya-therapeutics-inc.
Location
Newark, California
Newark, California
United States
United States
California
California
San Francisco
San Francisco
Number of Employees (Ranges)
11 – 50
0
Phone Number
+493641220
0
+15104563700
Public/Private
Private
0
Total Funding Amount (USD)
64,000,000
Official Website
orayainc.com
Wellfound ID
oraya-therapeutics

Find more companies like Oraya Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.